Sort   by:  
 Page size 
UnknownThe Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice.
Not available
S-EPMC9799175 | biostudies-literature
UnknownMajor role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.
Not available
S-EPMC7874916 | biostudies-literature
UnknownDiagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies.
Not available
S-EPMC5468543 | biostudies-literature
UnknownSustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity.
Not available
S-EPMC11522391 | biostudies-literature
Unknown2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225 | biostudies-literature
UnknownConvalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
Not available
S-EPMC8604729 | biostudies-literature
UnknownEconomic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.
Not available
S-EPMC7322334 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownEffect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
Not available
S-EPMC8456390 | biostudies-literature
UnknownEffect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132 | biostudies-literature
Sort   by:  
 Page size